跳至主要内容
临床试验/NCT01644942
NCT01644942已完成不适用

Identification in Obese Patients of the Mechanisms Involved in Intramuscular Lipid Accumulation.

University Hospital, Montpellier1 个研究点 分布在 1 个国家目标入组 33 人开始时间: 2008年5月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
33
试验地点
1
主要终点
lipid accumulation in skeletal muscle

研究概览

简要总结

The study aims to determine in obese patients the implication of intramuscular lipid accumulation in relation with insulin resistance and defect in lipid oxidation.

详细描述

Obese insulin sensitive and obese insulin resistant patients undergo a glucose tolerance test, indirect calorimetry during exercise and muscular biopsy.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
盲法
None

入排标准

年龄范围
40 Years 至 70 Years(Adult, Older Adult)
性别
Male
接受健康志愿者
否

入选标准

  • •Obese patients with a Body Mass Index (BMI) between 30 and 40 kg/m2
  • •Patients who do not practice physical exercise (Voorips index < 9)
  • •Age between 40 and 70 years- Male gender
  • •Fast blood glucose <1,10 g/l and no hypoglycemic treatment
  • •Signed informed consent
  • •Social security affiliation
  • •Absence of anti VIH, anti hepatitis C antibodies, and HBS antigen
  • •Normal biological tests
  • •Non smoking persons

排除标准

  • •Patients who refuse the anti-VIH, anti-hepatitis C antibodies, and HBS antigens tests
  • •Patients treated by anticoagulant, b blockers, lipopenic, or anti-inflammatory.
  • •Patients with a contraindication to muscular exercise (retinopathy, coronaropathy, nephropathy) and to muscular biopsy
  • •Allergy to local anaesthetic

研究组 & 干预措施

Insulin sensitive patients

Other

干预措施: Lipid accumulation analysis (Other)

Insulin resistant patients

Other

干预措施: Lipid accumulation analysis (Other)

结局指标

主要结局

lipid accumulation in skeletal muscle

时间窗: 1 month

次要结局

  • lipid accumulation in myotubes from obese patients(1 month)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验